MPLT SCHEDULE 13D/A: SEC filing
An amendment to a Schedule 13D was
Filed with the SEC on · accession 0001104659-26-098444
MPLT filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 18, 2026. An amendment to a Schedule 13D was filed for MapLight Therapeutics, Inc. (MPLT), indicating a change in a major shareholder's ownership position or intentions. The stock moved +5.1% by the first close after the filing.
Summary of the filing
An amendment to a Schedule 13D was filed for MapLight Therapeutics, Inc. (MPLT), indicating a change in a major shareholder's ownership position or intentions. The filing text available does not disclose specific details of the amendment.
Key details
How MPLT stock reacted
Close before
$11.24
Aug 17, 2026
First close after
+5.11%
$11.82
5 trading days
+1.02%
$11.36
Since filing
-38.37%
$6.93
✦ Ask GOAX AI about this filing — what it means for MPLT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MPLT?
Click hereFrequently asked questions
What did MPLT file with the SEC on Aug 18, 2026?
MPLT filed a SCHEDULE 13D/A (SEC filing). An amendment to a Schedule 13D was filed for MapLight Therapeutics, Inc. (MPLT), indicating a change in a major shareholder's ownership position or intentions. The filing text available does not disclose specific details of the amendment.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
How did MPLT stock react to this filing?
MPLT closed at $11.24 before the filing and $11.82 on Aug 18, 2026 (+5.11%). Five trading days later: $11.36 (+1.02%).
Other MPLT SEC filings
- EFFECT · SEC filingSep 23, 2026
- 424B3 · Secondary offeringSep 23, 2026
- S-1 · SEC filingSep 18, 2026
- S-1 · SEC filingSep 9, 2026
- SCHEDULE 13G · SEC filingAug 20, 2026
- 8-K · Secondary offeringAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 8-K · Fda approvalJul 27, 2026
- 8-K · Board changeJun 24, 2026
- 8-K · Fda approvalJun 22, 2026
Get alerts when MPLT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days